Roivant Sciences Ltd. (ROIVW) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 London, 英国. 现任CEO为 Matthew Gline.
ROIVW 拥有 IPO日期为 2021-09-27, 620 名全职员工, 在 NASDAQ Global Market, 市值为 $1.97B.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
